BioCentury | Aug 2, 2004
Clinical News

Tectin: Phase II started

International Wex Technologies Inc. (TSX:WXI; WXITF), Vancouver, B.C. Product: Tectin Business: Neurology Molecular target: Na channel Description: Sodium channel blocker derived from puffer fish Indication: Treat patients with chronic cancer pain Endpoint: NA Status: Phase...
BioCentury | Jan 19, 2004
Strategy

Ion channel players

...potassium channel located in hippocampus Modulator of undisclosed mechanism Age-related memory loss Preclin (w/ Yamanouchi) International Wex...
BioCentury | Jun 25, 2001
Clinical News

Tetrodin: Completed Phase Ib/Ic study

International Wex Technologies Inc. (CDNX:WXI; WXITF), Vancouver, B.C. Product: Tetrodin Business: Neurological Therapeutic category: Ion channel modulation Target: Sodium channels Description: Sodium channel blocker analgesic Indication: Treat pain and opioid withdrawal End point: Safety Status:...
BioCentury | Apr 9, 2001
Clinical News

Tetrodin: Began Phase Ib/Ic testing

International Wex Technologies Inc. (CDNX:WXI; WXITF), Vancouver, B.C. Product: Tetrodin Business: Neurological Therapeutic category: Ion channel modulation Target: Sodium channels Description: Sodium channel blocker analgesic Indication: Treat pain and opioid withdrawal End point: Safety Status:...
Items per page:
1 - 4 of 4
BioCentury | Aug 2, 2004
Clinical News

Tectin: Phase II started

International Wex Technologies Inc. (TSX:WXI; WXITF), Vancouver, B.C. Product: Tectin Business: Neurology Molecular target: Na channel Description: Sodium channel blocker derived from puffer fish Indication: Treat patients with chronic cancer pain Endpoint: NA Status: Phase...
BioCentury | Jan 19, 2004
Strategy

Ion channel players

...potassium channel located in hippocampus Modulator of undisclosed mechanism Age-related memory loss Preclin (w/ Yamanouchi) International Wex...
BioCentury | Jun 25, 2001
Clinical News

Tetrodin: Completed Phase Ib/Ic study

International Wex Technologies Inc. (CDNX:WXI; WXITF), Vancouver, B.C. Product: Tetrodin Business: Neurological Therapeutic category: Ion channel modulation Target: Sodium channels Description: Sodium channel blocker analgesic Indication: Treat pain and opioid withdrawal End point: Safety Status:...
BioCentury | Apr 9, 2001
Clinical News

Tetrodin: Began Phase Ib/Ic testing

International Wex Technologies Inc. (CDNX:WXI; WXITF), Vancouver, B.C. Product: Tetrodin Business: Neurological Therapeutic category: Ion channel modulation Target: Sodium channels Description: Sodium channel blocker analgesic Indication: Treat pain and opioid withdrawal End point: Safety Status:...
Items per page:
1 - 4 of 4